Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Help your patients see convenient insulin therapy more clearly.

Give your patients another option towards glycemic control.
Humalog Mix25 twice-a-day – basal and mealtime insulin analogues conveniently combined in a single pen – may be just what they have been looking for.

Open the dialogue to Humalog.

Insulin lispro (marketed by Eli Lilly and Company as “Humalog”) is a fast acting insulin analogue; it was the first insulin analogue.

It was engineered through recombinant DNA technology so that the penultimate lysine and proline residues on the C-terminal end of the B-chain were reversed. This modification did not alter receptor binding, but blocked the formation of insulin dimers and hexamers. This allowed larger amounts of active monomeric insulin to be available for postprandial (after meal) injections.

It has been shown by Shimoda et al. that, when comparing three insulin delivery methods, i.v. (intravenous) regular insulin, s.c. (subcutaneous) insulin Lispro, and s.c. regular insulin, that s.c. insulin Lispro performs almost as well as i.v. regular insulin in handling meal disturbances. S.c. regular insulin performed worse than s.c. insulin lispro, resulting in postprandial glucose peaks, in addition to postprandial hypoglycemia.

More on Wikipedia

Brand name: Humalog Mix 25
Generic name/category: 25% Insulin lispro injection rDNA origin, 75% insulin lispro protamine suspension
Company: Lilly
Country/Market: Canada, North America
Indication(s)/use: diabetes
Target: Healthcare Professionals (HCP)
Tagline: Open the dialogue to Humalog.
Medium: Print ad
Size/duration: single-page
Publication/Aired: CMAJ – August 4, 2009

To see all of this brand's ads on AdPharm, click here
5 views
Aug 11, 2009

Visit AdPharm.net for more pharmaceutical ads

Because you’re in the business of moving mountains… we’re in the business of supporting you

Reimbursement issues, cash flow, vaccine schedules, and many other daily distractions–the practice of medicine clearly has its challenges. As specialists in vaccines, at sanofi pasteur, our commitment to you and your practice means we’re ready to help you overcome those challenges every day. Online vaccine ordering, practice and patient information, and inventory monitoring solutions are a few of the tools we offer to help you stay focused on disease prevention.

Greater together

Generic name/category: corporate ad, vaccines
Company: Sanofi Pasteur
Country/Market: USA, North America
Indication(s)/use: viral infections
Target: Healthcare Professionals (HCP)
Tagline: Greater together
Medium: Print ad
Size/duration double-page spread
Publication/Aired: Contemporary Pediatrics July 2009

To see all of this brand’s ads on AdPharm, click here

Drops over the next 18 years: 13140

As a doctor, you know hell need IOP-lowering for the long term.

Keep this in mind and prescribe BAK-free Travatan Z Solution.

Brand name: Travatan Z
Generic name/category: Travoprost, Ophtalmology
Company: Alcon
Country/Market: USA, North America
Indication(s)/use: Reduction of elevated Intraocular Pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Target: Healthcare Professionals (HCP)
Publication: Ophtalmology Times June 2009

Surviving an MI is death defying

Omacor can help improve your patients’ chance of survival post-MI.

Agency: Life Healthcare

Brand name: Omacor
Generic name/category: Omega-3-acid ethyl esters 90
Company: Solvay
Country/Market: UK, Europe
Indication(s)/use: Endogenous hypertriglyceridemia and adjuvant treatment in secondary prevention after myocardial infarction
Target: Consumers (DTC) / Healthcare Professionals (HCP) / Trade
Tagline: Optimise survival after MI
Publication: Magazine or other Month Year